Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (7 ops.)
Latest filing published 25 Sept 2026 for Beam Therapeutics Inc.. Read the official filing
Filing timeline
BuySaleGiuseppe Ciaramella
Insider track record
Disclosed buys
0
Disclosed sells
7
Signal history
Giuseppe Ciaramella: trading record in brief
Giuseppe Ciaramella is a declared insider of Beam Therapeutics Inc. (senior executive), with filings sourced from SEC (Form 4). We count 31 filings; the first trade dates from 30 September 2020 and the latest from 24 September 2026.
On the market, this insider has only sold: 7 sales, €6.3M in total. Besides market trades, the filings include 5 share grants and 18 option exercises. Since January 2026: no purchases and 1 sale on the market.
The latest filing, published on 25 September 2026, reports a transaction in Beam Therapeutics Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Giuseppe Ciaramella
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations30 total
123,407 shares0Common StockSEC:0001193125-26-402814:0
6,505 sharesCommon StockSEC:0001193125-26-277509:0
29,000 sharesCommon StockSEC:0001193125-26-277509:1
11,810 shares@ US$24.582.9% of flowCommon StockSEC:0001193125-26-144054:0
40,000 shares0Common StockSEC:0001193125-26-140508:0
35,000 shares@ US$17.005.8% of flowCommon StockSEC:0001193125-26-076544:0
7,434 shares@ US$18.35061.4% of flowCommon StockSEC:0000950170-25-050856:0
35,000 shares0Common StockSEC:0000950170-25-049763:0
53,500 shares@ US$0.670.4% of flowCommon StockSEC:0000950170-24-138447:0
51,110 shares@ US$26.355914.1% of flowCommon StockSEC:0000950170-24-124085:0
27,318 shares@ US$0.670.2% of flowCommon StockSEC:0000950170-24-115031:0
4,534 shares@ US$32.121.6% of flowCommon StockSEC:0000950170-24-041426:0
35,000 shares0Common StockSEC:0000950170-24-040151:0
90,900 shares@ US$0.670.7% of flowCommon StockSEC:0000950170-23-054850:0
69,438 shares@ US$7.225.2% of flowCommon StockSEC:0000950170-23-034518:0
21,846 shares@ US$7.221.6% of flowCommon StockSEC:0000950170-23-034518:1
155,324 shares@ US$32.0651.2% of flowCommon StockSEC:0000950170-23-034518:2
1,206 shares@ US$7.220.1% of flowCommon StockSEC:0000950170-23-034518:3
1,206 shares@ US$32.010.4% of flowCommon StockSEC:0000950170-23-034518:4
1,918 shares@ US$30.310.6% of flowCommon StockSEC:0000899243-23-010818:0
20,000 shares0Common StockSEC:0000899243-23-010138:0
9,106 shares@ US$0.670.1% of flowCommon StockSEC:0000899243-23-000973:0
4,500 shares@ US$0.670.0% of flowCommon StockSEC:0000899243-23-000237:0
18,211 shares@ US$0.670.1% of flowCommon StockSEC:0000899243-22-038538:0
15,000 shares0Common StockSEC:0000899243-22-013489:0
25 of 30 declarations
